Aurinia Pharmaceuticals (AUPH) stock forecast for 2026. Forecast tables and graphs.







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Aurinia Pharmaceuticals (AUPH) stock forecast for 2026

Updated: May 18, 2024 (13:06)

Sector: Healthcare

The share price of Aurinia Pharmaceuticals Inc. (AUPH) now

What analysts predict: $10.86
52-week High/Low: $12.43 / $4.71

50/200 Day Moving Average: $5.11 / $7.46

This figure corresponds to the Average Price over the previous 50/200 days. For Aurinia Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Aurinia Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Aurinia Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aurinia Pharmaceuticals stock price in 2026. How much will one Aurinia Pharmaceuticals share be worth in 2026? Is it worth taking profit / loss on AUPH stock now or waiting? What are analysts' forecasts for Aurinia Pharmaceuticals stock?

We forecast Aurinia Pharmaceuticals stock performance using neural networks based on historical data on AUPH stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Aurinia Pharmaceuticals Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Aurinia Pharmaceuticals analysts is $10.86. Today 200 Day Moving Average is the resistance level (7.46 $). 50 Day Moving Average is the support level (5.11 $).




Historical and forecast chart of Aurinia Pharmaceuticals Inc. stock

The chart below shows the historical price of Aurinia Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AUPH stock price can be found in the table below.


Aurinia Pharmaceuticals Inc. is a late stage clinical biopharmaceutical company. The company focuses on the development and commercialization of treatments for target groups of patients with serious illnesses. Voklosporin develops for several indications. Voclosporine is an exploratory therapy. He is developing voklosporin for the treatment of lupus nephritis (LN) and other proteinuric diseases. He also puts forward the solution of Voclosporin Ophthalmic (VOC), a topical formation, for the treatment of dry eye syndrome (DES). Voclosporin is a calcineurin inhibitor (CNI). By inhibiting calcineurin, voclosporin blocks IL-2 expression and T-cell mediated immune responses and stabilizes the podocyte in the kidney.

Aurinia Pharmaceuticals (AUPH) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 7.42 7.05 8.03 12.26 %
Feb 8.01 7.48 8.69 13.86 %
Mar 8.52 7.51 9.35 19.68 %
Apr 8.97 8.05 9.49 15.13 %
May 9.85 8.96 10.59 15.33 %
Jun 11.26 10.34 11.97 13.55 %
Jul 11.66 11.21 12.91 13.15 %
Aug 12.95 11.52 14.46 20.34 %
Sep 11.04 9.96 12.17 18.14 %
Oct 11.57 10.50 12.74 17.59 %
Nov 11.94 10.62 13.01 18.36 %
Dec 11.16 10.14 12.30 17.56 %

Aurinia Pharmaceuticals information and performance

Aurinia Pharmaceuticals Address

#1203-4464 MARKHAM STREET, VICTORIA BC, BC, CA

Market Capitalization: 825 220 000 $

Market capitalization of the Aurinia Pharmaceuticals Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AUPH shares in the company outstanding by the market price of one share.

EBITDA: -47 000 000 $

EBITDA of Aurinia Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.43

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.462
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 128.21

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.761

Enterprise Value (EV) /Revenue

EV To EBITDA: -7.69

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 143019000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Aurinia Pharmaceuticals price target for 2026 by month


Target values for the price of one Aurinia Pharmaceuticals share for Jan 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Jan 2026 is: 7.42.
In Jan, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 12.260% volatility is expected.
Pessimistic target level: 7.05
Optimistic target level: 8.03

Target values for the price of one Aurinia Pharmaceuticals share for Feb 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Feb 2026 is: 8.01.
In Feb, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 13.864% volatility is expected.
Pessimistic target level: 7.48
Optimistic target level: 8.69

Target values for the price of one Aurinia Pharmaceuticals share for Mar 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Mar 2026 is: 8.52.
In Mar, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 19.679% volatility is expected.
Pessimistic target level: 7.51
Optimistic target level: 9.35

Target values for the price of one Aurinia Pharmaceuticals share for Apr 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Apr 2026 is: 8.97.
In Apr, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 15.129% volatility is expected.
Pessimistic target level: 8.05
Optimistic target level: 9.49

Target values for the price of one Aurinia Pharmaceuticals share for May 2026.

The weighted average target price per Aurinia Pharmaceuticals share in May 2026 is: 9.85.
In May, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 15.327% volatility is expected.
Pessimistic target level: 8.96
Optimistic target level: 10.59

Target values for the price of one Aurinia Pharmaceuticals share for Jun 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Jun 2026 is: 11.26.
In Jun, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 13.554% volatility is expected.
Pessimistic target level: 10.34
Optimistic target level: 11.97

Target values for the price of one Aurinia Pharmaceuticals share for Jul 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Jul 2026 is: 11.66.
In Jul, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 13.151% volatility is expected.
Pessimistic target level: 11.21
Optimistic target level: 12.91

Target values for the price of one Aurinia Pharmaceuticals share for Aug 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Aug 2026 is: 12.95.
In Aug, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 20.344% volatility is expected.
Pessimistic target level: 11.52
Optimistic target level: 14.46

Target values for the price of one Aurinia Pharmaceuticals share for Sep 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Sep 2026 is: 11.04.
In Sep, the Negative dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 18.142% volatility is expected.
Pessimistic target level: 9.96
Optimistic target level: 12.17

Target values for the price of one Aurinia Pharmaceuticals share for Oct 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Oct 2026 is: 11.57.
In Oct, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 17.588% volatility is expected.
Pessimistic target level: 10.50
Optimistic target level: 12.74

Target values for the price of one Aurinia Pharmaceuticals share for Nov 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Nov 2026 is: 11.94.
In Nov, the Positive dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 18.355% volatility is expected.
Pessimistic target level: 10.62
Optimistic target level: 13.01

Target values for the price of one Aurinia Pharmaceuticals share for Dec 2026.

The weighted average target price per Aurinia Pharmaceuticals share in Dec 2026 is: 11.16.
In Dec, the Negative dynamics for Aurinia Pharmaceuticals Inc. shares will prevail with possible monthly volatility of 17.562% volatility is expected.
Pessimistic target level: 10.14
Optimistic target level: 12.30



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.